We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The Johnson & Johnson Vaccine for COVID-19.
- Authors
Livingston, Edward H.; Malani, Preeti N.; Creech, C. Buddy
- Abstract
This JAMA Patient Page explains how the Johnson & Johnson COVID-19 vaccine, likely to be the third SARS-CoV-2 vaccine approved for widespread use, uses an adenovirus 26 vector to deliver coronavirus DNA to host cells to produce spike proteins and safely and effectively induce immunity.
- Subjects
COVID-19; VIRAL vaccines; JOHNSON &; Johnson (Company); SARS-CoV-2; ADENOVIRUS diseases; IMMUNITY
- Publication
JAMA: Journal of the American Medical Association, 2021, Vol 325, Issue 15, p1575
- ISSN
0098-7484
- Publication type
journal article
- DOI
10.1001/jama.2021.2927